Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Tar

CORALVILLE, IA / ACCESSWIRE / January 5, 2022 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle oncology

Related Keywords

Jenene Thomas , Kostenloser Wertpapierhandel , Francesl Johnson , Hc Wainwright Bioconnect , Viewpoint Molecular Targeting Inc , Company Melanoma , Viewpoint Molecular Targeting , Chief Executive Officer , Bioconnect Conference , Molecular Targeting , Neuroendocrine Tumor , Investor Inquiries , Viewpoint , Olecular , Targeting , Present , Wainwright , Bioconnect , Conference ,